CYP2J2 Molecular Recognition: A New Axis for Therapeutic Design

Area of Science:

• Biochemistry and Molecular Biology
• Pharmacology and Drug Metabolism

Background:

• Cytochrome P450 (CYP) epoxygenases are heme-containing enzymes with dual roles in polyunsaturated fatty acid (PUFA) epoxidation and xenobiotic metabolism.
• Their position at a metabolic crossroads necessitates structure-function studies for understanding bioactive oxy-lipid synthesis, drug-PUFA interactions, and therapeutic development.
• Human CYP2J2 is a significant epoxygenase due to its role in cardiovascular physiology, making it a key therapeutic target.

Purpose of the Study:

• To review and contextualize early epoxygenase research with recent advances in CYP epoxygenase enzymology.
• To utilize CYP2J2 as a model system for highlighting seminal and recent findings in epoxygenase enzymology.
• To identify future research needs for the molecular characterization of CYP2J2 to enable novel therapeutic design.

Main Methods:

• Review of existing literature on epoxygenase discovery, activity, and enzymology.
• Focus on CYP2J2 as a model system, analyzing its interactions with PUFAs and xenobiotics.
• Examination of CYP2J2's tissue-specific roles in disease states and its structural features relevant to epoxygenase function.

Main Results:

• Discussion of CYP epoxygenases' dual functionality in PUFA and xenobiotic metabolism.
• Detailed review of CYP2J2's interactions with PUFAs and xenobiotics, and its physiological roles in cardiovascular health and disease.
• Highlighting of structural features enabling CYP2J2 epoxygenase function.

Conclusions:

• Improved understanding of epoxygenase structure-function is critical for therapeutic targeting.
• CYP2J2 serves as a valuable model for advancing epoxygenase enzymology and understanding its role in cardiovascular disease.
• Further molecular characterization of CYP2J2 is essential for developing new therapeutic strategies.